IA
KPRX icon

IFP Advisors’s Kiora Pharmaceuticals KPRX Stock Holding History

IFP Advisors’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5
Closed -$14K – 3923
2018
Q2 		$14K Buy
5
+1
+25% +$2.82K ﹤0.01% 2693
2018
Q1 		$25K Hold
4
– – ﹤0.01% 2243
2017
Q4 		$25K Sell
4
-1
-20% -$6.18K ﹤0.01% 2272
2017
Q3 		$30K Buy
5
+2
+67% +$12.7K ﹤0.01% 2338
2017
Q2 		$22K Hold
3
– – ﹤0.01% 2523
2017
Q1 		$35K Hold
3
– – ﹤0.01% 2144
2016
Q4 		$22K Hold
3
– – ﹤0.01% 2381
2016
Q3 		$24K Buy
+3
New +$32.1K ﹤0.01% 2295

Other funds holding KPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

IFP Advisors's KPRX Position: Q3 2018 in Review

IFP Advisors sold out of Kiora Pharmaceuticals (KPRX) in Q3 2018, closing a stake of 5 shares — an estimated $14K sold.

IFP Advisors first reported a position in KPRX in Q3 2016 and held it in 8 quarters. The position peaked at $35K in Q1 2017. 20 funds tracked by Wall St. Rank hold KPRX as of Q3 2018.

  • IFP Advisors reported no remaining Kiora Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • IFP Advisors sold 5 Kiora Pharmaceuticals shares in Q3 2018, an estimated $14K.
  • IFP Advisors first reported a position in Kiora Pharmaceuticals in Q3 2016 and held it in 8 quarters.
  • IFP Advisors's Kiora Pharmaceuticals position peaked at $35K in Q1 2017.
  • 20 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q3 2018.

Based on IFP Advisors's 13F filing for Q3 2018, filed 25 Oct 2018.